AC
PACB icon

AXQ Capital’s Pacific Biosciences PACB Stock Holding History

AXQ Capital’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,974
Closed -$14.5K – 1255
2026
Q1 		$14.5K Buy
+10,974
New +$19.6K ﹤0.01% 970
2024
Q1 		– Sell
-14,900
Closed -$146K – 818
2023
Q4 		$146K Buy
+14,900
New +$122K 0.04% 573
2023
Q2 		– Sell
-68,580
Closed -$794K – 492
2023
Q1 		$794K Buy
+68,580
New +$682K 0.32% 89

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AXQ Capital's PACB Position: Q2 2026 in Review

AXQ Capital sold out of Pacific Biosciences (PACB) in Q2 2026, closing a stake of 10,974 shares — an estimated $14.5K sold.

AXQ Capital first reported a position in PACB in Q1 2023 and held it in 3 quarters. The position peaked at $794K in Q1 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • AXQ Capital reported no remaining Pacific Biosciences position as of Q2 2026 after selling out during the quarter.
  • AXQ Capital sold 10,974 Pacific Biosciences shares in Q2 2026, an estimated $14.5K.
  • AXQ Capital first reported a position in Pacific Biosciences in Q1 2023 and held it in 3 quarters.
  • AXQ Capital's Pacific Biosciences position peaked at $794K in Q1 2023.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.